Ionis Pharmaceuticals Overview
Ionis Pharmaceuticals Target Price
Analysts' 12-month price predictions for IONS.
Share Price
$32.96
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-10-09 | GuggenheimDebjit Chattopadhyay | $65 |  97.2% upside |  |
| 2024-08-02 | BMO CapitalKostas Biliouris | $60 | 82% upside | |
| 2024-07-24 | Leerink PartnersMani Foroohar | $62 | 88.1% upside | |
| 2024-07-22 | JefferiesAkash Tewari | $77 | 133.6% upside | |
| 2024-07-22 | Goldman SachsSalveen Richter | $33 | 0.1% upside | |
| 2024-07-16 | JefferiesAkash Tewari | $75 | 127.5% upside | |
| 2024-06-27 | Stifel NicolausPaul Matteis | $53 | 60.8% upside | |
| 2024-06-17 | RBC CapitalLuca Issi | $70 | 112.4% upside | |
| 2024-06-14 | Tudor PickeringWilliam Pickering | $44 | 33.5% upside | |
| 2024-05-17 | BMO CapitalKostas Biliouris | $67 | 103.3% upside | |
| 2023-02-03 | Leerink Partners | $34 | 3.2% upside | |
| 2022-12-21 | Morgan Stanley | $40 | 21.4% upside | |
| 2022-08-10 | Citigroup | $28 |  15% downside | |
| 2022-08-10 | RBC Capital | $64 | 94.2% upside | |
| 2022-06-21 | Piper SandlerDo Kim | $55 | 66.9% upside | |
| 2022-06-21 | Leerink Partners | $27 | 18.1% downside | |
| 2022-05-09 | Morgan Stanley | $30 | 9% downside | |
| 2022-02-24 | NeedhamJoseph Stringer | $60 | 82% upside | |
| 2022-02-24 | RBC CapitalLuca Issi | $67 | 103.3% upside | |
| 2022-02-01 | Bank of America SecuritiesJason Gerberry | $30 | 9% downside | |
| 2021-11-04 | BarclaysGena Wang | $33 | 0.1% upside | |
| 2021-10-18 | LaidlawYale Jen | $68 | 106.3% upside | |
| 2021-05-10 | UBSEsther Rajavelu | $37.5 | 13.8% upside | |
| 2021-05-05 | OppenheimerKevin DeGeeter | $63 | 91.1% upside | |